Zobrazeno 1 - 10
of 251
pro vyhledávání: '"Mauro Maniscalco"'
Autor:
Anna Agnese Stanziola, Claudio Candia, Gerardo Nazzaro, Antonio Caso, Claudia Merola, Lorena Gallotti, Mauro Maniscalco
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
BackgroundSevere eosinophilic asthma (SEA) is often linked to a dysregulation in the Interleukin-(IL)-5 axis. Mepolizumab, a humanized monoclonal antibody, reduces eosinophils by directly binging to IL-5, potentially restoring homeostatic eosinophil
Externí odkaz:
https://doaj.org/article/e3b480ae901942b8b0dd234a85692764
Quality of life and work functionality in severe asthma patients: the impact of biological therapies
Autor:
Veruscka Leso, Claudio Candia, Daniela Pacella, Antonio Molino, Caterina Nocera, Mauro Maniscalco, Ivo Iavicoli
Publikováno v:
Journal of Occupational Medicine and Toxicology, Vol 19, Iss 1, Pp 1-15 (2024)
Abstract Background Severe asthma can cause poor health status, poor health-related quality of life (HRQoL) and an impaired functioning at work. However, to date, limited data are available on the impact of the biological therapies on such outcomes.
Externí odkaz:
https://doaj.org/article/722651cd103d4f69b9887832b4471bcd
Autor:
Debora Paris, Letizia Palomba, Maria Cristina Albertini, Annabella Tramice, Lorenzo Motta, Eleonora Giammattei, Pasquale Ambrosino, Mauro Maniscalco, Andrea Motta
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-15 (2023)
Abstract In COVID-19 clinical symptoms can persist even after negativization also in individuals who have had mild or moderate disease. We here investigated the biomarkers that define the post-COVID-19 clinical state analyzing the exhaled breath cond
Externí odkaz:
https://doaj.org/article/b65186310e434b0a8e74d4bde03fdea7
Autor:
Pasquale Ambrosino, Giuseppina Marcuccio, Giuseppina Raffio, Roberto Formisano, Claudio Candia, Fabio Manzo, Germano Guerra, Ennio Lubrano, Costantino Mancusi, Mauro Maniscalco
Publikováno v:
Life, Vol 14, Iss 7, p 899 (2024)
Over the past 15 years, the paradigm of viewing the upper and lower airways as a unified system has progressively shifted the approach to chronic respiratory diseases (CRDs). As the global prevalence of CRDs continues to increase, it becomes evident
Externí odkaz:
https://doaj.org/article/6c00da4ea45a45a6b60e5a3ab75f7714
Autor:
Silvestro Ennio D’Anna, Alessandra Maria Vitale, Giuseppa D’Amico, Celeste Caruso Bavisotto, Pasquale Ambrosino, Francesco Cappello, Mauro Maniscalco, Antonella Marino Gammazza
Publikováno v:
Biology, Vol 13, Iss 6, p 359 (2024)
As reported by the World Health Organization (WHO), about 10–20% of people have experienced mid- to long-term effects following SARS-CoV-2 infection, collectively referred to as post-COVID-19 condition or long-COVID, including some neurovegetative
Externí odkaz:
https://doaj.org/article/718fa25bc0ac47bb832a9d8dd0dfb068
Autor:
Stefano Sanduzzi Zamparelli, Carmen Lombardi, Claudio Candia, Paola Rebecca Iovine, Gaetano Rea, Michele Vitacca, Pasquale Ambrosino, Marialuisa Bocchino, Mauro Maniscalco
Publikováno v:
Journal of Clinical Medicine, Vol 13, Iss 7, p 2026 (2024)
Idiopathic pulmonary fibrosis (IPF) is a chronic and irreversible fibrotic disease whose natural history is characterised by a progressive worsening of the pulmonary function, exertional dyspnoea, exercise intolerance, reduced physical activity, and
Externí odkaz:
https://doaj.org/article/1b8e29b5a6b142e3bf1c495e13a67df9
Autor:
Antonino Di Stefano, Isabella Gnemmi, Umberto Rosani, Mauro Maniscalco, Silvestro Ennio D’Anna, Paola Brun, Vitina Carriero, Francesca Bertolini, Bruno Balbi, Fabio Luigi Massimo Ricciardolo
Publikováno v:
International Journal of Molecular Sciences, Vol 25, Iss 6, p 3287 (2024)
Notch signaling is involved in the prevention of cell differentiation and cell fate in various organs, including the lungs. We aimed to determine the transcriptomic and protein expression of Notch receptors, their ligands, and related transcription f
Externí odkaz:
https://doaj.org/article/da86bc830824401083cb4adddb5d498e
Autor:
Matteo Vigna, Piero Ceriana, Mara Santomassimo, Michele Vitacca, Mauro Maniscalco, Nicolino Ambrosino
Publikováno v:
Monaldi Archives for Chest Disease (2023)
Survivors of severe COVID-19 requiring hospital admission may suffer from short- and long-term sequelae, including disability and reduced physical performance. Vaccination and pulmonary rehabilitation (PR) are effective tools against COVID-19 effects
Externí odkaz:
https://doaj.org/article/217dabb31ccb460fafbdf7079841d55a
Autor:
Pasquale Ambrosino, Stefano Sanduzzi Zamparelli, Marco Mosella, Roberto Formisano, Antonio Molino, Giorgio Alfredo Spedicato, Antimo Papa, Andrea Motta, Matteo Nicola Dario Di Minno, Mauro Maniscalco
Publikováno v:
Annals of Medicine, Vol 54, Iss 1, Pp 3234-3249 (2022)
Background Endothelial dysfunction has been proposed to play a key role in the pathogenesis of coronavirus disease 2019 (COVID-19) and its post-acute sequelae. Flow-mediated dilation (FMD) is recognized as an accurate clinical method to assess endoth
Externí odkaz:
https://doaj.org/article/3ed7d1395f314122a3dc55efb8f55461
Autor:
Antonino Di Stefano, Francesca Dossena, Isabella Gnemmi, Silvestro Ennio D’Anna, Paola Brun, Bruno Balbi, Alessio Piraino, Antonio Spanevello, Francesco Nucera, Vitina Carriero, Francesca Bertolini, Mauro Maniscalco, Ian M. Adcock, Gaetano Caramori, Fabio L. M. Ricciardolo
Publikováno v:
Respiratory Research, Vol 23, Iss 1, Pp 1-13 (2022)
Abstract Background Identification of COPD patients with a rapid decline in FEV1 is of particular interest for prognostic and therapeutic reasons. Objective To determine the expression of markers of inflammation in COPD patients with rapid functional
Externí odkaz:
https://doaj.org/article/99e754ddc55e464b92dedc9b4ae49c18